ClinConnect ClinConnect Logo
Search / Trial NCT07006441

Cardiac Rehabilitation in Coronary Artery Bypass Graft Surgery

Launched by ATLAS UNIVERSITY · May 28, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Coronary Artery Disease Coronary Artery Bypass Graft Surgery Preoperative Cardiac Rehabilitation Postoperative Cardiac Rehabilitation

ClinConnect Summary

This clinical trial is studying how different types of cardiac rehabilitation programs can help patients who are having coronary artery bypass graft (CABG) surgery. Specifically, researchers want to find out if starting rehabilitation before the surgery, combined with rehabilitation after, leads to better recovery than just doing rehabilitation after the surgery alone. They will look at various factors, such as how well patients can move, their lung function, muscle strength, pain levels, fear of movement, and overall quality of life after the surgery.

To participate in this trial, you need to be between the ages of 18 and 65, have had CABG surgery, and have a heart function measurement (called ejection fraction) greater than 40%. You also should be able to understand and communicate in your language. However, if you have an active infection, a current tumor, a recent history of certain blood clots, or other significant health issues that could affect the study, you may not be eligible. If you join the study, you can expect to engage in rehabilitation activities designed to support your recovery both before and after your surgery, helping you get back to your daily life as quickly and safely as possible.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having undergone coronary artery bypass graft surgery
  • Ejection Fraction (EF) \> 40%
  • Being between the ages of 18-65
  • Being able to speak, read and understand in their own language
  • Volunteering to participate in the study
  • Exclusion Criteria:
  • Having an active or suspected infection
  • Presence of an active tumour
  • History of thrombophlebitis or pulmonary embolism within the last 3 months
  • Having an orthopaedic, neurological or cardiovascular disease that may affect the assessments

About Atlas University

Atlas University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in scientific inquiry and patient care, Atlas University fosters collaboration among multidisciplinary teams to explore groundbreaking therapeutic interventions. The university's robust infrastructure supports a wide range of clinical studies, aimed at enhancing treatment outcomes and improving health equity. By integrating education and research, Atlas University not only contributes to the scientific community but also trains the next generation of healthcare professionals to meet the evolving challenges of medicine.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Hikmet Ucgun, PT, PhD

Principal Investigator

Atlas University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported